AHA urges FDA to quickly resolve shortages of certain critical drug products

AHA urges the Food and Drug Administration (FDA) to take any and all steps possible to expedite the resolution of the worsening shortages of small-volume parenteral solutions that are so fundamental to patient care in hospitals.

Related Resources

Letter
Public
AHA expresses disappointment that the Agency for Healthcare Research and Quality is shutting down the National Guidelines Clearinghouse.
Letter
Public
AHA comments on the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Advisory
Member
On June 12, the Centers for Medicare…
Bibliography/Link Page
SAMHSA's The Dialogue produced
Case Studies
Members in Action: Improve Quality and Patient Outcomes<
Letter
Public
AHA comments on the Centers for Medicare & Medicaid Services’ hospital inpatient prospective payment system proposed rule for fiscal year 2019.